Wealthspire Advisors (Maryland)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-538
| Closed | -$50K | – | 518 |
|
|
2019
Q1 | $50K | Buy |
538
+447
| +491% | +$41.5K | ﹤0.01% | 890 |
|
|
2018
Q4 | $7K | Buy |
91
+2
| +2% | +$154 | ﹤0.01% | 1584 |
|
|
2018
Q3 | $8K | Buy |
89
+18
| +25% | +$1.62K | ﹤0.01% | 1587 |
|
|
2018
Q2 | $7K | Sell |
71
-19
| -21% | -$1.87K | ﹤0.01% | 1645 |
|
|
2018
Q1 | $11K | Buy |
90
+22
| +32% | +$2.69K | ﹤0.01% | 1513 |
|
|
2017
Q4 | $9K | Buy |
68
+46
| +209% | +$6.09K | ﹤0.01% | 1615 |
|
|
2017
Q3 | $3K | Buy |
22
+3
| +16% | +$409 | ﹤0.01% | 1891 |
|
|
2017
Q2 | $2K | Buy |
19
+7
| +58% | +$737 | ﹤0.01% | 1960 |
|
|
2017
Q1 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 1762 |
|
|
2016
Q2 | – | Sell |
-6
| Closed | – | – | 1683 |
|
|
2016
Q1 | $0 | Sell |
6
-3
| -33% | – | ﹤0.01% | 1736 |
|
|
2015
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 1588 |
|